background
etiolog
agent
sever
acut
respiratori
syndrom
sar
recent
identifi
posit
singlestrand
rna
ssrna
coronaviru
sarscov
littl
known
dynam
chang
viral
replic
form
sar
case
object
evalu
whether
sarscov
infect
replic
peripher
blood
mononuclear
cell
pbmc
infect
person
reveal
dynam
chang
viru
cours
diseas
studi
design
peripher
blood
mononuclear
cell
collect
sar
case
infect
infecti
sourc
test
negativestrand
rna
minu
rna
replic
intermedi
positivestrand
rna
genom
rna
sarscov
cours
hospit
revers
transcriptionpolymeras
chain
reaction
rtpcr
result
sarscov
minu
rna
detect
pbmc
sar
patient
viral
replic
form
pbmc
detect
period
day
postonset
diseas
plu
rna
detect
longer
period
day
postonset
conclus
sarscoronaviru
infect
replic
within
pbmc
sar
patient
viral
replic
pbmc
seem
subject
selflimit
sarscoronaviru
replic
mononuclear
cell
peripher
blood
pbmc
sar
patient
confirm
pathogen
sever
acut
respiratori
syndrom
sar
novel
coronaviru
term
sarscoronaviru
sarscov
posit
singlestrand
rna
ssrna
viru
classifi
within
order
nidoviral
famili
coronavirida
genu
coronaviru
although
viru
identifi
abbrevi
bnibernhardnocht
institut
tropic
medicin
hamburg
germani
level
covcoronaviru
mhvmous
hepat
viru
pcrpolymeras
chain
reaction
minu
rnarepl
negativestrand
rna
plu
rnapositivestrand
genom
rna
rtrevers
transcript
sarssever
acut
respiratori
syndrom
scasodium
citrat
anticoagul
genom
sequenc
analyz
lee
et
al
marra
et
al
tsang
et
al
poutanen
et
al
littl
known
biolog
featur
cell
infect
mous
hepat
viru
contain
positiveand
negativestrand
rna
viru
mhv
member
genu
coronaviru
gener
accept
minu
rna
princip
templat
positivestrand
rna
synthesi
mhv
infect
baric
yount
sarscov
report
concern
exist
replic
negativestrand
rna
sar
patient
order
evalu
whether
sarscov
infect
peripher
blood
mononuclear
cell
pbmc
infect
person
ii
whether
viru
replic
pbmc
iii
reveal
dynam
chang
viru
cours
diseas
carri
followup
investig
plusand
minusrna
form
sar
patient
patient
report
infect
sarscov
sourc
patient
male
patient
femal
patient
femal
three
six
member
singl
famili
april
travel
hangzhou
wuhan
citi
meet
member
famili
among
eldest
sister
beij
fever
cough
start
april
famili
member
suspect
eldest
sister
infect
sarscov
took
protect
measur
famili
gather
eldest
sister
return
beij
soon
admit
hospit
diagnos
definit
sar
case
april
three
famili
member
report
came
back
hangzhou
citi
april
sister
patient
began
show
sarsassoci
symptom
fever
cough
pain
chest
etc
april
two
april
april
three
patient
admit
special
ward
hospit
design
isol
infecti
diseas
strict
contain
condit
three
patient
infect
wuhan
citi
subject
help
interrupt
spread
infect
day
admiss
hospit
everi
day
thereaft
ml
venou
blood
sca
collect
three
patient
isol
pbmc
extract
rna
perform
laboratori
biosafeti
level
bsl
pbmc
isol
ad
equal
volum
lymphocyt
separ
medium
ml
freshli
collect
blood
wash
twice
suspend
ml
normal
salin
solut
nacl
rna
extract
blood
plasma
ml
wash
pbmc
pharyng
gargl
solut
use
trizol
reagent
process
accord
manufactur
instruct
gibco
brl
revers
transcript
rt
carri
use
u
superscript
ii
rnase
h
revers
transcriptas
ml
firststrand
buffer
invitrogen
ml
mm
dntp
mix
ml
dtt
ml
pmolml
primer
ml
extract
rna
ml
distil
water
made
volum
ml
rt
reaction
perform
min
bniouta
primer
antisens
use
cdna
synthesi
plu
genom
rna
sarscov
primer
sens
use
cdna
synthesi
minusrna
sarscov
sequenc
primer
use
rtreaction
follow
pcr
primer
set
bniinsbniina
recommend
bernhardnocht
institut
bni
tropic
medicin
hamburg
germani
bernhardnocht
institut
cdna
synthes
primer
bniouta
antisens
primer
sens
respect
use
templat
detect
plu
minusrna
first
round
amplif
reaction
ml
total
volum
contain
ml
pcr
buffer
invitrogen
ml
mm
mgcl
ml
dntp
mix
final
mm
ml
mm
primer
ml
u
platinum
taq
dna
polymeras
invitrogen
ml
cdna
templat
thermal
cycl
condit
recommend
bernhardnocht
institut
tropic
medicin
hamburg
germani
bernhardnocht
institut
compris
min
cycl
decreas
per
cycl
cycl
two
microlit
first
pcr
product
use
templat
second
round
pcr
condit
second
pcr
use
first
one
except
primer
first
round
replac
primer
set
bniinsbniina
first
cycl
appli
first
round
pcr
follow
cycl
instead
cycl
pcr
product
analyz
agaros
gel
pcr
product
sequenc
directli
use
dideoxi
termin
sequenc
reaction
dyenam
et
dye
termin
kit
amersham
bioscienc
automat
dna
analysi
system
model
megabac
amersham
bioscienc
rna
extract
plasma
pbmc
pharyng
gargl
solut
collect
three
sar
patient
reversetranscrib
cdna
antisens
primer
bniouta
follow
nestedpcr
expect
size
amplifi
product
bp
correspond
expect
molecular
weight
respect
sequenc
stretch
rna
polymeras
gene
sarscov
genom
rna
sarscov
detect
sampl
collect
admiss
day
follow
fig
longest
detect
period
genom
rna
sarscov
day
postonset
diseas
fig
sens
primer
use
cdna
synthesi
sarscov
replic
minu
rna
templat
follow
amplif
procedur
use
detect
genom
plu
rna
minusrna
could
detect
pbmc
sar
case
fig
detect
period
shorter
plu
rna
fig
nuclear
acid
sequenc
analysi
pcr
product
amplifi
plu
minusrna
show
full
homolog
sarscov
genom
sequenc
data
shown
sarscoronavir
minu
rna
posit
genom
rna
could
appear
simultan
alon
pbmc
show
characterist
cours
sar
fig
admiss
hospit
three
patient
distinct
manifest
sar
fever
cough
chest
pain
plu
rna
present
pharyng
gargl
solut
pbmc
detect
blood
plasma
minu
rna
form
detect
pbmc
patient
patient
neg
sarscov
minu
rna
pbmc
day
one
day
later
patient
condit
becam
wors
sampl
posit
sar
plu
minusrna
day
admiss
sarscoronavir
minusrna
detect
pbmc
patient
two
test
neg
day
minusrna
pbmc
patient
longer
detect
till
may
result
two
patient
shown
fig
briefli
detect
period
sarscoronavir
replic
intermedi
minusstrand
rna
three
patient
within
day
postonset
diseas
plu
genom
rna
remain
detect
longer
period
day
postonset
fig
essenti
minusstrand
rna
detect
pbmc
coronaviru
replic
use
genom
well
subgenom
plu
minu
rna
latter
synthes
discontinu
transcript
process
mechan
yet
well
establish
sawicki
sawicki
lai
holm
least
five
subgenom
mrna
detect
northern
hybrid
rna
sarscovinfect
cell
paul
et
al
accordingli
sarscov
use
minu
rna
kind
replic
intermedi
replic
cycl
cell
minusrna
copi
sarscov
genom
detect
sampl
sar
patient
reason
indic
presenc
replic
viru
sarscoronavir
replic
intermedi
minu
strand
rna
well
plu
strand
rna
detect
success
pbmc
three
patient
nuclear
acid
sequenc
analys
pcr
product
show
full
homolog
sarscov
genom
sequenc
support
idea
sarscoronaviru
passiv
adher
pbmc
infect
cell
replic
within
first
report
show
presenc
sarscoronaviru
minu
rna
suppos
repres
replic
intermedi
rna
durat
rna
pbmc
cours
sar
patient
indic
viru
attack
replic
pbmc
may
partial
help
explain
mild
leukopenia
lymphopenia
observ
sar
patient
poutanen
et
al
tsang
et
al
detect
period
sarscov
replic
pbmc
three
patient
less
week
suggest
viral
replic
cell
probabl
selflimit
conclud
sarscoronaviru
infect
also
replic
within
pbmc
sar
patient
presenc
minu
rna
reflect
replic
intermedi
cov
pbmc
limit
within
period
day
postonset
diseas
suggest
replic
pbmc
subject
selflimit
result
rais
question
requir
studi
pbmc
fact
mixtur
variou
type
cell
find
type
pbmc
main
target
invas
replic
sarscov
import
search
molecul
receptor
bind
viru
surfac
cell
facilit
design
develop
drug
block
bind
sarscov
suscept
cell
also
result
valuabl
help
determin
administr
antiviru
immunomodul
sar
clinic
practic
